In last trading session, Channel Therapeutics Corporation (AMEX:CHRO) saw 0.22 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $1.01 trading at $0.09 or 9.89% at ring of the bell on the day assigns it a market valuation of $6.09M. That closing price of CHRO’s stock is at a discount of -494.06% from its 52-week high price of $6.00 and is indicating a premium of 55.45% from its 52-week low price of $0.45. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 76360.0 shares which gives us an average trading volume of 147.99K if we extend that period to 3-months.

For Channel Therapeutics Corporation (CHRO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Channel Therapeutics Corporation (AMEX:CHRO) trade information

Upright in the green during last session for gaining 9.89%, in the last five days CHRO remained trading in the green while hitting it’s week-highest on Wednesday, 01/08/25 when the stock touched $1.01 price level, adding 8.18% to its value on the day. Channel Therapeutics Corporation’s shares saw a change of 57.57% in year-to-date performance and have moved 57.57% in past 5-day. Channel Therapeutics Corporation (AMEX:CHRO) showed a performance of 20.97% in past 30-days. Number of shares sold short was 58233.0 shares which calculate 0.26 days to cover the short interests.